BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7755225)

  • 1. Management of health care workers after inadvertent exposure to tuberculosis: a guide for the use of preventive therapy.
    Stead WW
    Ann Intern Med; 1995 Jun; 122(12):906-12. PubMed ID: 7755225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptance of isoniazid preventive therapy by health care workers after tuberculin skin test conversion.
    Camins BC; Bock N; Watkins DL; Blumberg HM
    JAMA; 1996 Apr; 275(13):1013-5. PubMed ID: 8596233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis among elderly persons: an outbreak in a nursing home.
    Stead WW
    Ann Intern Med; 1981 May; 94(5):606-10. PubMed ID: 7235393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoniazid preventive therapy in areas of high isoniazid resistance.
    Sterling TR; Brehm WT; Frieden TR
    Arch Intern Med; 1995 Aug 7-21; 155(15):1622-8. PubMed ID: 7618985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with the treatment of latent tuberculosis infection among health-care workers at a midwestern teaching hospital.
    Shukla SJ; Warren DK; Woeltje KF; Gruber CA; Fraser VJ
    Chest; 2002 Nov; 122(5):1609-14. PubMed ID: 12426260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lessons learned from tuberculosis outbreak cases].
    Kato S; Kuwabara K
    Kekkaku; 2014 Feb; 89(2):77-88. PubMed ID: 24716362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy.
    Selwyn PA; Sckell BM; Alcabes P; Friedland GH; Klein RS; Schoenbaum EE
    JAMA; 1992 Jul 22-29; 268(4):504-9. PubMed ID: 1619742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk for transmission of Mycobacterium tuberculosis at the bedside and during autopsy.
    Templeton GL; Illing LA; Young L; Cave D; Stead WW; Bates JH
    Ann Intern Med; 1995 Jun; 122(12):922-5. PubMed ID: 7755227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.
    Aisu T; Raviglione MC; van Praag E; Eriki P; Narain JP; Barugahare L; Tembo G; McFarland D; Engwau FA
    AIDS; 1995 Mar; 9(3):267-73. PubMed ID: 7755915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: a risk-benefit and cost-effectiveness analysis.
    Salpeter SR; Sanders GD; Salpeter EE; Owens DK
    Ann Intern Med; 1997 Dec; 127(12):1051-61. PubMed ID: 9412307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a nosocomial tuberculosis control program at an urban teaching hospital.
    LoBue PA; Catanzaro A
    Chest; 1998 May; 113(5):1184-9. PubMed ID: 9596292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of tuberculosis and other mycobacterial diseases.
    Am Rev Respir Dis; 1983 Jun; 127(6):790-6. PubMed ID: 6859666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost effectiveness analysis of isoniazid preventive therapy to the contacts of tuberculosis patients under Japanese settings].
    Yoshiyama T
    Kekkaku; 2000 Nov; 75(11):629-41. PubMed ID: 11140086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of latent tuberculosis infection in HIV infected persons.
    Woldehanna S; Volmink J
    Cochrane Database Syst Rev; 2004; (1):CD000171. PubMed ID: 14973947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent tuberculosis infection among health care workers at a general hospital in Santiago de Cuba.
    Borroto S; Gámez D; Díaz D; Martínez Y; Ferrer AI; Velásquez Y; Llanes MJ; González E
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1510-4, i. PubMed ID: 22008765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A risk to patients and health care workers.
    Pearson ML; Jereb JA; Frieden TR; Crawford JT; Davis BJ; Dooley SW; Jarvis WR
    Ann Intern Med; 1992 Aug; 117(3):191-6. PubMed ID: 1352093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1997 Sep; 46(RR-15):1-10. PubMed ID: 9332982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis prevention: cost-effectiveness analysis of isoniazid chemoprophylaxis.
    Rose DN; Schechter CB; Fahs MC; Silver AL
    Am J Prev Med; 1988; 4(2):102-9. PubMed ID: 3134928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
    Sterling TR; Brehm WT; Moore RD; Chaisson RE
    Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Phthisiophobia": the difficult recognition of transmission of tuberculosis to health care workers.
    Riva MA; Ploia PR; Rocca S; Cesana G
    Med Lav; 2013; 104(5):359-67. PubMed ID: 24180084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.